Terms: = Kidney tumors AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
243 results:
1. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract] [Full Text] [Related]
2. Survival assessment of nephron-sparing surgery or radical nephrectomy in children with unilateral Wilms tumor receiving adjuvant chemotherapy: a retrospective cross-sectional study.
Wu XW; Zhou PP; Dong Q
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1095-1102. PubMed ID: 38375715
[TBL] [Abstract] [Full Text] [Related]
3. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
4. Acute kidney injury in patients with cancer receiving anti-PD-1/PD-L1 antibodies: incidence, risk factors, and prognosis.
Lou Q; Gong J; Ye B; Yu R; Bu S; Li Y; Zhu B; Shao L
Ren Fail; 2023 Dec; 45(1):2238823. PubMed ID: 37491871
[TBL] [Abstract] [Full Text] [Related]
5. An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study.
Internò V; Massari F; Rudà R; Maiorano BA; Caffo O; Procopio G; Bracarda S; Atzori F; Passarelli A; Bersanelli M; Stellato M; Fornarini G; Galli L; Ortega C; Zanardi E; Incorvaia L; Facchini G; Giron Berrios JR; Ricotta R; Santoni M; Funaioli C; Trerotoli P; Porta C; Rizzo M
ESMO Open; 2023 Aug; 8(4):101598. PubMed ID: 37467658
[TBL] [Abstract] [Full Text] [Related]
6. Factors associated with survival in paediatric and adolescent renal cell carcinoma: a population-based study.
Zhao L; Liu W; Chu L; Luo L
ANZ J Surg; 2023 Nov; 93(11):2710-2715. PubMed ID: 37458221
[TBL] [Abstract] [Full Text] [Related]
7. Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy.
Khaleel S; Truong H; Jiang S; K-Lee P; Davelman B; Gordon D; Benfante N; Arora A; Ostrovnaya I; Tickoo S; Coleman J; Hakimi AA; Russo P
Urol Oncol; 2023 Sep; 41(9):391.e5-391.e11. PubMed ID: 37423816
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations.
Wang K; Duan P; Chen X; Yang Q; Feng G; Diao L; Zhang Z; Yao X
Cancer Med; 2023 Jul; 12(13):14149-14156. PubMed ID: 37325945
[TBL] [Abstract] [Full Text] [Related]
9. Genetically predicted vitamin C levels significantly affect patient survival and immunotypes in multiple cancer types.
Yuan J; Zhang YH; Hua X; Hong HQ; Shi W; Liu KX; Liu ZX; Huang P
Front Immunol; 2023; 14():1177580. PubMed ID: 37283769
[TBL] [Abstract] [Full Text] [Related]
10. A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor.
Tsuji T; Asato R; Kada S; Kitamura M; Tamaki H; Mizuta M; Tanaka S; Watanabe Y; Hori R; Kojima T; Shinohara S; Takebayashi S; Maetani T; Harada H; Kitani Y; Kumabe Y; Tsujimura T; Honda K; Ichimaru K; Ushiro K; Omori K
Auris Nasus Larynx; 2024 Feb; 51(1):86-98. PubMed ID: 37248104
[TBL] [Abstract] [Full Text] [Related]
11. Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma.
Kawamura K; Miyai K; Sato K; Matsukuma S; Honda K; Ito K; Tsuda H
Cancer Sci; 2023 Aug; 114(8):3411-3422. PubMed ID: 37226638
[TBL] [Abstract] [Full Text] [Related]
12. Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?
Korkmaz M; Eryılmaz MK; Koçak MZ; Er MM; Hendem E; Demirkıran A; Araz M; Karaağaç M; Artaç M
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147975
[TBL] [Abstract] [Full Text] [Related]
13. The aggregate index of systemic inflammation may predict mortality in COVID-19 patients with chronic renal failure.
Ercan Z; Evren Öztop K; Pınar M; Varim C; Dheir H; Karacaer C; Yaylaci S; Bilal Genç A; Çekiç D; Nalbant A; Cihad Genç A
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3747-3752. PubMed ID: 37140323
[TBL] [Abstract] [Full Text] [Related]
14. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
15. Urine supernatant reveals a signature that predicts survival in clear-cell renal cell carcinoma.
Daza J; Salomé B; Okhawere K; Bane O; Meilika KN; Korn TG; Qi J; Xe H; Patel M; Brody R; Kim-Schulze S; Sfakianos JP; Lewis S; Rich JM; Zuluaga L; Badani KK; Horowitz A
BJU Int; 2023 Jul; 132(1):75-83. PubMed ID: 36797809
[TBL] [Abstract] [Full Text] [Related]
16. Sarcomatoid renal cell carcinoma: MRI features and their association with survival.
Cheng M; Duzgol C; Kim TH; Ghafoor S; Becker AS; Causa Andrieu PI; Gangai N; Jiang H; Hakimi AA; Vargas HA; Woo S
Cancer Imaging; 2023 Feb; 23(1):16. PubMed ID: 36793052
[TBL] [Abstract] [Full Text] [Related]
17. Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal Masses.
Žalimas A; Kubiliūtė R; Žukauskaitė K; Sabaliauskaitė R; Trakymas M; Letautienė S; Kaubrienė EM; Ušinskienė J; Ulys A; Jarmalaitė S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555747
[TBL] [Abstract] [Full Text] [Related]
18. Acute kidney injury as an independent predicting factor for stage 3 or higher chronic kidney disease after nephrectomy.
Yang X; Zhang T; Zhou H; Ni Z; Wang Q; Wu J; Chen Q; Qiu M; Wang Y; Fu T; Ye M; Zhang J; Xue W; Mou S
Urol Oncol; 2023 Mar; 41(3):149.e1-149.e9. PubMed ID: 36463084
[TBL] [Abstract] [Full Text] [Related]
19. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
Urol Oncol; 2023 Feb; 41(2):110.e7-110.e14. PubMed ID: 36456452
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
Hsieh HC; Wang CL; Chen CS; Yang CK; Li JR; Wang SS; Cheng CL; Lin CY; Chiu KY
PLoS One; 2022; 17(12):e0278038. PubMed ID: 36454803
[TBL] [Abstract] [Full Text] [Related]
[Next]
